Expert 340B compliance, split billing, and pharmacy benefit optimization for eligible covered entities.
The 340B Drug Pricing Program allows eligible covered entities to purchase outpatient drugs at significantly reduced prices. However, maximizing 340B savings while staying compliant with HRSA requirements demands expertise in eligibility management, split billing, and contract pharmacy oversight. CIAxil provides end-to-end 340B program management to protect your program and grow your savings.
“The 340B program is one of the most powerful financial tools available to safety-net providers — when managed correctly, it transforms patient care capacity.”
From initial registration and TPA oversight to ongoing audit defense, our team ensures your 340B program operates in full compliance with HRSA guidelines while maximizing every eligible dollar.
Protect your program, maximize savings, and reinvest in patient care with expert 340B management.
Maintaining program integrity and preparing your covered entity for HRSA review.
HRSA audits examine patient eligibility, diversion controls, duplicate discount prevention, and contract pharmacy compliance. CIAxil conducts proactive internal audits using HRSA’s own methodology — so when an audit comes, you are fully prepared with organized documentation and defensible processes.